Emerging Viral Infections in Rheumatic Diseases

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 2, 2011, Pages 236-246

  Khasnis, Atul A ^a   Schoen, Robert T ^b   Calabrese, Leonard H ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

Alphavirus; Chikungunya; Emerging viral infections; Epidemiology; Rheumatic diseases

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANALGESIC AGENT; ANTIPYRETIC AGENT; ANTIRETROVIRUS AGENT; CHIKUNGUNYA VACCINE; CHLOROQUINE; CORTICOSTEROID; CORTISONE; IMMUNOGLOBULIN; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTHRALGIA; ARTICLE; BREEDING; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CLINICAL FEATURE; DENGUE VIRUS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HEPATITIS B VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PARVOVIRUS B19; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; INFECTIOUS ARTHRITIS; POLYARTERITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMATIC REVIEW; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

COMMUNICABLE DISEASES; HUMANS; RHEUMATIC DISEASES; VIRUS DISEASES;

EID: 80855144222     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.01.008     Document Type: Article

References (104)

1. Calabrese L.H. Emerging viral infections and arthritis: the role of the rheumatologist. Nat Clin Pract Rheumatol 2008, 4(1):2-3.
2. Tyler K.L. Emerging viral infections of the central nervous system: part 1. Arch Neurol 2009, 66(8):939-948.
3. Khasnis A.A., Nettleman M.D. Global warming and infectious disease. Arch Med Res 2005, 36(6):689-696.
4. Cleaveland S., Laurenson M.K., Taylor L.H. Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence. Philos Trans R Soc Lond B Biol Sci 2001, 356(1411):991-999.
5. Holmes E.C. The phylogeography of human viruses. Mol Ecol 2004, 13(4):745-756.
6. Wilke C.O., Wang J.L., Ofria C., Lenski R.E., Adami C. Evolution of digital organisms at high mutation rates leads to survival of the flattest. Nature 2001, 412(6844):331-333.
7. Quiñones-Mateu M.E., Arts E.J. Virus fitness: concept, quantification, and application to HIV population dynamics. Curr Top Microbiol Immunol 2006, 299:83-140.
8. Charleston M.A., Robertson D.L. Preferential host switching by primate lentiviruses can account for phylogenetic similarity with the primate phylogeny. Syst Biol 2002, 51(3):528-535.
9. Gould E.A., Higgs S. Impact of climate change and other factors on emerging arbovirus diseases. Trans R Soc Trop Med Hyg 2009, 103(2):109-121.
10. Peterson A.T. Shifting suitability for malaria vectors across Africa with warming climates. BMC Infect Dis 2009, 9:59.
11. Kilpatrick A.M., Meola M.A., Moudy R.M., Kramer L.D. Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog 2008, 4(6):e1000092.
12. Reisen W.K., Meyer R.P., Presser S.B., Hardy J.L. Effect of temperature on the transmission of western equine encephalomyelitis and St Louis encephalitis viruses by Culex tarsalis (Diptera:Culicidae). J Med Entomol 1993, 30(1):151-160.
13. Rohani A., Wong Y.C., Zamre I., Lee H.L., Zurainee M.N. The effect of extrinsic incubation temperature on development of dengue serotype 2 and 4 viruses in Aedes aegypti (L.). Southeast Asian J Trop Med Public Health 2009, 40(5):942-950.
14. Chikungunya reaches northern Italy: effect of global warming?. Arch Dis Child 2008, 93(4):312. No authors listed.
15. Simard F., Nchoutpouen E., Toto J.C., Fontenille D. Geographic distribution and breeding site preference of Aedes albopictus and Aedes aegypti (Diptera: culicidae) in Cameroon. Central Africa J Med Entomol 2005, 42(5):726-731.
16. Patz J.A., Reisen W.K. Immunology, climate change and vector-borne diseases. Trends Immunol 2001, 22(4):171-172.
17. Sun H.Y., Singh N. Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients. Curr Opin Infect Dis 2009, 22(4):394-402.
18. Feng Z., Yang Y., Xu D., Zhang P., McCauley M.M., Glasser J.W. Timely identification of optimal control strategies for emerging infectious diseases. J Theor Biol 2009, 259(1):165-171.
19. Renaud C.J., Manjit K., Pary S. Dengue has a benign presentation in renal transplant patients: a case series. Nephrology (Carlton) 2007, 12(3):305-307.
20. Maganti R.M., Reveille J.D., Williams F.M. Therapy insight: the changing spectrum of rheumatic disease in HIV infection. Nat Clin Pract Rheumatol 2008, 4(8):428-438.
21. Vassilopoulos D, Calabrese LH. Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther 215;10(5):215.
22. Vassilopoulos D., Manolakopoulos S. Rheumatic manifestations of hepatitis. Curr Opin Rheumatol 2010, 22(1):91-96.
23. Te H.S., Jensen D.M. Epidemiology of Hepatitis B and C Viruses: a global overview. Clin Liver Dis 2010, 14(1):1-21.
24. Belizna C.C., Hamidou M.A., Levesque H., Guillevin L., Shoenfeld Y. Infection and vasculitis. Rheumatology (Oxford) 2009, 48(5):475-482.
25. Pagnoux C., Seror R., Henegar C., Mahr A., Cohen P., Le Guern V., et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010, 62(2):616-626.
26. Morens D.M., Folkers G.K., Fauci A.S. The challenge of emerging and re-emerging infectious diseases. Nature 2004, 430(6996):242-249.
27. Reveille J.D., Williams F.M. Infection and musculoskeletal conditions: rheumatologic complications of HIV infection. Best Pract Res Clin Rheumatol 2006, 20(6):1159-1179.
28. Walker U.A., Tyndall A., Daikeler T. Rheumatic conditions in human immunodeficiency virus infection. Rheumatology (Oxford) 2008, 47(7):952-959.
29. Calabrese L.H., Kirchner E., Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 2005, 35(3):166-174.
30. Reveille J.D. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arthritis Rheum 2000, 30(3):147-166.
31. Strauss J.H., Straus E.G. The alphaviruses: gene expression, replication, and evolution. Microbiol Mol Biol Rev 1994, 58:491-562.
32. Her Z., Kam Y.-W., Lin R.T.P., Ng L.F.P. Chikungunya: a bending reality. Microbes Infection 2009, 11:1165-1176.
33. Staples J.Breiman, Powers A. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 2009, 49:942-948.
34. Chevillon C., Briant L., Renaud F., Devaux The Chikungunya threat: an ecological and evolutionary perspective. Trends Microbiol 2008, 16(2):80-88.
35. Simon F., Savini H., Parola P. Chikungunya: a paradigm of emergence and globalization of vector-borne disease. Med Clinics North Am 2008, 93:1323-1343.
36. Gould E., Coutard B., Malet H., Morin B., Jamal S., Weaver S., et al. Understanding the alphaviruses: recent research on important emerging pathogens and progress towards their control. Antiviral Res 2010, 87(2):111-124.
37. Rulli N.E., Melton J., Wilmes A., Ewart G., Mahalingam S. The molecular and cellular aspects of arthritis due to alphavirus infections: lesson learned from Ross River virus. Ann NY Acad Med 2007, 1102:96-108.
38. Calabrese L.H. Emerging viral infections and arthritis: the role of the rheumatologist. Nat Clin Pract Rheumatol 2007, 4:2-3.
39. Griffin D.E. Alphaviruses. Fields Virology 2001, 917-962. Lippincott Williams & Wilkins, Philadelphia (PA). 4th edition. D.M. Knipe, P.M. Howley (Eds.).
40. Lumsden W.H.R. An epidemic of virus disease in Southern Province. Tanganika territory in 1952-1953 II. General description and epidemiology. Trans R Soc Trop Med Hyg 1955, 49:33-57.
41. Robinson M.C. An epidemic of virus disease in Southern Province. Tanganika territory in 1952-1953. Trans R Soc Trop Med Hyg 1955, 49:28-32.
42. Lumsden W.H.R. An epidemic of virus disease in southern province. Tanganyika territory, in 1952-1953. II General description and epidemiology. Trans R Soc Trop Med Hyg 1955, 49:133-157.
43. Williams M.C., Woodall J.P., Gillett J.D. O'Nyong-nyong fever: an epidemic virus disease in East Africa: VII. Virus isolations from man and serological studies up to July, 1961. Trans R Soc Trop Med Hyg 1965, 59:186-197.
44. Laine M., Luukkainen R., Toivanen A. Sindbis viruses and other alphaviruses as cause of human arthritic disease. J Int Med 2004, 256:457-471.
45. Jacups S.P., Whelan P.I., Currie B.J. Ross River virus and Barmah Forest virus infections: a review of history, ecology, and predictive models, with implications for tropical northern Australia. Vector Borne Zoonotic Dis 2008, 8:283-297.
46. Powers A.M., Brault A.C., Tesh R.B., Weaver S.C. Re-emergence of Chikungunya and O'nyung-nyung viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol 2000, 81:471-479.
47. Sergon K., Njuguna C., Kalani R., Ofula V., Onyango C., Konongoi L.S., et al. Seroprevalence of Chikungunya virus infection on Lamu Island, Kenya, October, 2004. Am J Trop Med Hyg 2008, 78:333-337.
48. Sergon K., Yahaya A.A., Brown J., Bedja S.A., Mlindasse M., Agata N., et al. Seroprevalence of chikungunya virus infection on Grande Cormore Island, Union of the Cormoros, 2005. Am J Trop Med Hyg 2007, 76:1189-1193.
49. Sissoko D., Malvy D., Giry C., Delmas G., Paquet C., Gabrie P., et al. Outbreak of chikungunya fever in Mayotte. Cormoros archipelago, 2005-2006. Trans R Soc Trop Med Hyg 2008, 102:780-786.
50. Beesoon S., Funkhouser E., Kotea N., Spielman A., Robich R.M. Chikungunya fever. Mauritius, 2006. Emerg Infect Dis 2008, 14:337-338.
51. Sang R.C., Ahmed O., Faye O., Kelly C.L., Yahaya A.A., Mmadi I., et al. Entomologic investigations of a chikungunya virus epidemic in the Union of the Comoros, 2005. Am J Trop Med Hyg 2008, 78:77-82.
52. Josseran L., Pauet C., Zehgnoun A., Caillere N., Le Tertre A., Solet J.L., et al. Chikungunya disease outbreak, Reunion Island. Emerging Infect Dis 2006, 12:1994-1995.
53. Gerardin P., Barau G., Michault A., Binter M., Randrianavio H., Choker G., et al. Multidisciplinary prospective study of mother-to-child Chikungunya virus infections on the Island of La Reunion. Plos Med 2008, 5:413-423.
54. Mavalankar D., Shastri P., Bandyopadhyay T., Parmar J., Ramani K. Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India. Emerg Infect Dis 2008, 14:412-415.
55. Schuffenecker I., Iteman I., Michault A., Murri S., Frangeul L., Vaney M.C., et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. Plos Med 2006, 3:1058-1070.
56. Charrel R.N., de Lamballerie X., Raoult D. The globalization of vectorborne diseases. New Engl J Med 2007, 356:769-771.
57. Yergolkar P.N., Tandale B.V., Arankalle V.A., et al. Chikungunya outbreaks caused by African genotype. India Emerg Infect Dis 2006, 12:1580-1583.
58. Tsetsarkin K.A., Vanlandingham D.L., McGee C.E., Higgs S. A single mutation in Chikungunya virus affects specificity and epidemic potential. PLoS Path 2007, 4:e201.
59. Vazeille M., Moutailler S., Coudrier D., Rousseaux C., Khun H., Huerre M., et al. Two Chikungunya isolates from the outbreak of La Reunion (Indian ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PloS One 2007, 2:e1168.
60. de Lamballerie X., Leroy E., Charrel R.N., Ttestsarkin K., Higgs S., Gould E.A. Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come?. Virol J. 2008, 5:1-4.
61. Nelson M.J. Aedes aegypti: biology and ecology 1986, Pan American Health Organization, Washington (DC).
62. Paupy C., Delatte H., Bagny L., Corbel V., Fontenille D. Aedes albopictus, an arbovirus vector: from the darkness to the light. Microbes Infect 2009, 11(14-15):1177-1185.
63. Benitez M.A. Climate change could affect mosquito-borne diseases in Asia. Lancet 2009, 373:1070.
64. Knudsen A.B. Global distribution and continuing spread of Aedes albopictus. Parassitologia 1995, 37:91-97.
65. Outbreak and spread of chikungunya. Wkly Epidemiol Rec 2007, 82:409-415. World Health Organization.
66. Simon F., Parola P., Grandadam M., Fourcade S., Oliver M., Brouqui P., et al. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Medicine 2007, 86:123-137.
67. Hochedez P., Jaureguiberry S., Debruyne M., et al. Chikungunya infection in travelers. Emerg Infect Dis 2006, 12:1565-1567.
68. Pfeffer M., Loscher T. Cases of chikungunya imported into Europe. Euro Surveill 2006, 11:E060316.
69. Lanciotti R., Kosoy O., Laven J.J., Panella A.J., Velez J.O., Lambert A.J., et al. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis 2007, 13:764-767.
70. Romi R., Majori G. An overview of the lesson learned in almost 20 years of fight against the "tiger" mosquito. Parassitologia 2008, 50:117-119.
71. Dalla Pozza G., Romi R., Severini C. Source and spread of Aedes mosquitoes in the Veneto region of Italy. J Am Mosq Control Assoc 1994, 10:589-592.
72. Weissman G. Gore's fever and Dante's Inferno: Chikungunya reaches Ravenna. FASEB J 2008, 22:635-638.
73. Angelini R., Finarelli A.C., Po C., Petropulacos K., Macini P., Fio C., et al. An outbreak of chikungunya fever in the province of Ravenna. Italy Euro Surveill 2007, 12(9):E070906.
74. Rezza G., Nicoletti L., Angelini R., Romi R., Finarelli A.C., Panning M. Infection with Chikungunya virus in Italy: an outbreak in temperate region. Lancet 2007, 370:1840-1846.
75. Bordi L., Carletti F., Castilletti C., Chiappini R., Sambro V., Cavrini F., et al. Presence of the A226V mutation in autochthonous and imported Italian chikungunya virus strains. Clin Infect Dis 2008, 47:428-429.
76. Charrel R., Lamballerie X., Raoult D. Seasonality of mosquitoes and chikungunya in Italy. Lancet 2008, 8:5-6.
77. Chen L.H., Wilson E. The role of the traveler in emerging infections and magnitude of travel. Med Clin North Am 2008, 92:1409-1432.
78. Parola P., de Lamballerie, Jourdan J., et al. Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis 2006, 12:1493-1499.
79. Update: chikungunya fever diagnosed among international travelers-United States, 2006. MMWR Morb Mortal Wkly Rep 2007, 56:276-277.
80. Reiskind M.H., Pesko K., Westbrook C., Mores C.N. Susceptibility of Florida mosquitoes to infection with chikungunya virus. Am J Trop Med Hyg 2008, 78:422-425.
81. Brighton S.W., Prozesky O.W., de la Harpe A.L. Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J 1983, 63:313-315.
82. Borgherini G., Poubeau P., Jossaume A., Gouix A., Cotte L., Michault A., et al. Persistent arthralgia associated with chikungunya virus: a study of 88 patients on Reunion Island. Clin Infect Dis 2008, 47:469-475.
83. Larrieu S., Puoderoux N., Pistone T., Filleul L., Receveur M.-C., Sissoko D., et al. Factors associated with persistence of arthralgia among chikungunya virus-infected travelers: report of 42 French cases. J Clin Virol 2010, 47:85-88.
84. Economopoulou A., Dominguez M., Helynck B., Sissoko D., Wichmann O., Quenel P., et al. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during 2005-2006 outbreak on Reunion. Epidemiol Infect 2009, 137:534-541.
85. Pialoux G., Gauzere B.-A., Jaureguiberry S., Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007, 7:319-327.
86. Das T., Jaffar-Bandjee M.C., Hoarau J.J., Krejbich-Trotot P., Denizot M., Lee-Pat-Yuen G., et al. Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus. Prog Neurobiol 2010, 91(2):121-129.
87. Mahendradas P., Ranganna S.K., Shetty R., et al. Ocular manifestations associated with chikungunya. Ophthalmology 2008, 115:287-291.
88. Renault P., Solet J.L., Sissoko D., et al. A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg 2007, 77:727-731.
89. Staikowsky F., Talarmin F., Grivard P., Souab A., Schuffenecker I., Le Rouxm K., et al. Prospective study of Chikungunya virus acute infection in the island of La Reunion during the 2005-2006 outbreak. PloS One 2009, 4:e7603.
90. Oliver M., Grandadam M., Marimoutou C., Rogier C., Botelho-Nevers E., Tolou H., et al. Persisting mixed cryoglobulinemia in chikungunya infection. PloS Negl Trop Dis 2009, 3:e374.
91. Laurent P., Le Roux K., Grivard P., et al. Development of a sensitive real-time reverse transciptase PCR assay with an internal control to detect and quantify chikungunya vius. Clin Chem 2007, 53:1408-1414.
92. Panning M., Grywna K., van Esbroeck M., Emmerich P., Drosten C. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis 2008, 8:2-3.
93. Litzba V., Schuffenecker I., Zeller H., et al. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods 2008, 149:175-179.
94. Couderc T., Khandoudi N., Grandadum M., et al. Prophylaxis and therapy for chikungunya virus Infection. J Infect Dis 2009, 200:516-523.
95. Rezza G. Chikungunya and West Nile virus outbreaks: what is happening in north-eastern Italy. Eur J Public Health 2009, 19:236-237.
96. Reiter P., Fontenille, Paupy C. Aedes albopictus as an epidemic vector of chikungunya virus infection: another emerging problem?. Lancet Infect Dis 2006, 6:463-464.
97. Edelman R., Tacket C.O., Wasserman S.S., et al. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg 2000, 62:681-685.
98. Wang E., Volkova E., Adams A.P., Forrester N., Xiao S.-H., Frolov I., et al. Chimeric alphavirus vaccine candidates for chikungunya. Vaccine 2008, 26:5030-5039.
99. Muthumani K., Lankaraman K.M., Laddy D.J., Sundaram S.G., Chung C.W., Sako E., et al. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine 2008, 26:5128-5134.
100. Jennings G., Bachmann M. The coming of age of virus-like particle vaccines. Biol Chem 2008, 389:521-536.
101. Akahata W., Yang Z.-Y., Anderson H., Sun S., Holdaway H.A., Kong W.-P., et al. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med 2010, 16(3):334-338.
102. Kumar D. Emerging viruses in transplantation. Curr Opin Infect Dis 2010, 23(4):374-378.
103. Calabrese L.H., Molloy E.S., Huang D., Ransohoff R.M. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. Arthritis Rheum 2007, 56(7):2116-2128.
104. Calabrese L.H., Molloy E.S. Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis 2008, 67(Suppl 3):iii64-iii65.